Table 1.

Association of the 2 LoF variants with PAM-AMA

 beta95% CIP-value
Ser539Trp−2.33−2.52, −2.152.50E-140
Asp563Gly−0.98−1.04, −0.921.12E-225
 beta95% CIP-value
Ser539Trp−2.33−2.52, −2.152.50E-140
Asp563Gly−0.98−1.04, −0.921.12E-225

The table shows the estimates resulting from the meta-analysis of the associations of LoF variants with PAM-AMA in the MDC-CC and in the MPP cohort. The results for the linear regression are adjusted for age, sex, and the first 10 genetic principal components. PAM-AMA is expressed in standardized units.

Abbreviations: CI, confidence interval; LoF, loss-of-function; MDC-CC, MDC-CC: Malmö Diet and Cancer-Cardiovascular cohort; MPP, Malmö Preventive Project cohort; PAM-AMA, peptidylglycine-α-amidating monooxygenase amidating activity.

Table 1.

Association of the 2 LoF variants with PAM-AMA

 beta95% CIP-value
Ser539Trp−2.33−2.52, −2.152.50E-140
Asp563Gly−0.98−1.04, −0.921.12E-225
 beta95% CIP-value
Ser539Trp−2.33−2.52, −2.152.50E-140
Asp563Gly−0.98−1.04, −0.921.12E-225

The table shows the estimates resulting from the meta-analysis of the associations of LoF variants with PAM-AMA in the MDC-CC and in the MPP cohort. The results for the linear regression are adjusted for age, sex, and the first 10 genetic principal components. PAM-AMA is expressed in standardized units.

Abbreviations: CI, confidence interval; LoF, loss-of-function; MDC-CC, MDC-CC: Malmö Diet and Cancer-Cardiovascular cohort; MPP, Malmö Preventive Project cohort; PAM-AMA, peptidylglycine-α-amidating monooxygenase amidating activity.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close